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Impaired NK11 T Cell Development and Early
IL-4 Production in CD1-Deficient Mice
Yi-Hua Chen, Nancy M. Chiu, Manas Mandal, CD1 family may have arisen from a primordial antigen-
presenting molecule in the same evolutionary periodNing Wang, and Chyung-Ru Wang
during which MHC class I and class II diverged. Consis-Gwen Knapp Center for Lupus and
tent with this notion, CD1 shares some features withImmunology Research
both class I and class II molecules. Like class I, butCommittee on Immunology
unlike class II, the expression and proper assembly ofDepartment of Pathology
CD1 is b2m-dependent but isnot dependent on invariantUniversity of Chicago
chain and DM. However, like class II but unlike class I,Chicago, Illinois 60637
CD1 trafficks to the MHC class II compartment (MIIC)
(Sugita et al., 1996) and does not require functional
TAP-1 and TAP-2 peptide transporter for its surface
Summary expression (Hanau et al., 1994; Brutkiewicz et al., 1995).
Thus, the CD1 family is proposed to represent a distinct
The MHC class Ib molecule, CD1, has been conserved but related third lineage of antigen-presenting mole-
throughout mammalian evolution. To assess the func- cules.
tion of CD1 in lymphocyte development, we generated The structural similarity of CD1 to antigen-presenting
mice with targeted disruption of the CD1.1 and CD1.2 molecules, sequence conservation throughout evolu-
genes. CD1-deficient mice have normal numbers of tion, and expression on antigen-presenting cells sug-
CD41 and CD81 T cells but marked reduction in NK1.1- gests that CD1 may act as a target antigen for T cell
bearing T cells, particularly those with a canonical recognition. Group 1 molecules present lipid (mycolic
gene rearrangement of Va14-Ja281. CD1-deficient acid) and glycolipid (lipoarabinomannan) antigens from
mice are unable to generate a rapid IL-4 response Mycobacteria to ab1 T cells (Beckman et al., 1994; Sie-
following systemic T cell activation but can generate ling et al., 1995), while the natural ligands of Group 2
effective antigen-specific Th2 responses. Thus, CD1 molecules remain elusive. A well-defined peptide-bind-
is required for the development of a specialized subset ing motif for mCD1 was identified by screening a ran-
of T lymphocytes with a monomorphic antigen recep- dom peptide-phage display library with soluble empty
tor. The rapid effector cytokine secretion of these T mCD1.1 produced in Drosophila cells (CastanÄ o et al.,
cells suggests that CD1 educates adaptive immune 1995). The CD1-binding peptides have a hydrophobic
cells to subserve functions of innate immunity. motif with an aromatic residue in positions 1 and 7 and
an aliphatic residue in position 4. Immunizing mice with
peptide-coated CD1 transfectants can raise CD1-
Introduction restricted peptide-specific cytotoxic T cells. It remains
to be tested whether mCD1 can also bind hydrophobic
The CD1 molecules are glycoproteins with MHC class nonpeptide antigens.
I-like structure, consisting of a 45 kDa heavy chain non- Recently, mouse CD1.1 was shown to be recognized
covalently associated with beta-2-microglobulin (b2m). by hybridomas generated from a unique subset of T
In contrast to conventional MHC molecules, CD1 genes cells, the NK11 T cells (Bendelac et al., 1995). These
display limited polymorphism and map outside of the cells express a number of markers at levels usually asso-
MHC complex in both humans and mice (Yu and ciated with activated/memory T cells such as HSAlow,
Milstein, 1989; Meisler et al., 1992). Each mammalian L-selectinlow, and Pgp1high. In addition, they express most
species examined possesses at least one to two classes known natural killer (NK) receptors, including NKR-P1,
of CD1 genes. Five CD1 genes in human (CD1a, -b, -c, Ly-49A, Ly-49C, and IL-2 receptor b chain (Bendelac,
-d, and -e) and two in the mouse (mCD1.1 and mCD1.2) 1995; Bix and Locksley, 1995; MacDonald, 1995). NK11
have been cloned and sequenced. Based on sequence T cells comprise approximately 0.5% of thymocytes (ac-
homology and tissue distribution, CD1 molecules are counting for 10%±20% of the mature thymocyte com-
divided into two classes, with human CD1a, -b, and -c partment), 1% of peripheral lymph node cells, 4% of
in Group 1 and human CD1d and both murine CD1.1 splenocytes, and 15%±50% of liver and bone marrow
and CD1.2 in Group 2 (Porcelli, 1995; Jullien et al., 1996). T cells (Bendelac, 1995). Unlike most mature class
Human CD1a, -b, and -c are expressed on immature I-restricted ab T cells, NK11 T cells are almost exclu-
thymocytes, professional antigen presenting cells, and sively either CD41 or CD42CD82 and have an intermedi-
some B cells (Cattoretti et al., 1987), while CD1d and ate level of expression of ab TCR (TCRint). Furthermore,
murine CD1 (mCD1) are detected on nearly all thymo- NK11 T cells have very restricted TCR usage. Most NK11
cytes, peripheral lymphocytes, epithelial cells in the gas- T cells use an invariant a chain, Va14-Ja281, paired with
trointestinal tract, and hepatocytes (Bleicher et al., Vb8, Vb7, or Vb2 chain (Arase et al., 1992; Lantz and
1990). Bendelac, 1994). The most striking characteristic of
Despite the similar intron±exon organization, the over- these cells is their ability to produce promptly large
all homology between CD1 and MHC class I is only amounts of cytokines, in particular IL-4, upon primary
25%±35% at theprotein level (Calabi and Milstein, 1986). stimulation through the TCR complex (Howe et al., 1989;
Similar sequence homology is also detected between Bendelac et al., 1992; Hayakawa et al., 1992; Zlotnik et
al., 1992; Arase et al., 1993; Yoshimoto et al., 1995a).CD1 and MHC class II molecules, suggesting that the
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As the earliest responding T cells, NK11 T cells might At the transcriptional level, CD1.1 mRNA is expressed
be a first line of defense and modulate the upcoming at higher levels than CD1.2 in all tissues tested except
adaptive immune responses by releasing a set of ef- the thymus (Bradbury et al., 1988, 1990). To inactivate
fector cytokines following in vivo activation. both CD1.1 and CD1.2, we constructed a targeting vec-
It remains unclear whether CD1 is the selection ele- tor in which a neomycin resistance gene (neo) is flanked
ment for all or only a subset of NK11 T cells and what by the DNAsequences derived from the 59 ends of CD1.1
function(s) CD1-restricted T cells play in immune re- and CD1.2 (Figure 1A). Homologous recombination in
sponse and homeostasis. In this study, we have gener- the targeting region results in the deletion of a 12 kb
ated CD1-deficient mice to study the role of CD1 in T cell DNA fragment encompassing the intervening sequence
development and the function of CD1-restricted NK11 T (z6 kb) between the two genes and exons 4 to 6 from
cells. Our results demonstrate that CD1 is the primary both CD1.1 and CD1.2. Partial DNA-sequencinganalysis
selecting element for the majority of NK11 T cells. Func- of the intervening sequence reveals that it contains an
tional analyses show that the CD1-restricted NK11 T cell L1 repeat, and the remaining sequenced region (z3 kb)
population is essential for the anti-CD3-induced early does not have sequence homology to any known genes
IL-4 burst but is not required for the differentiation of (unpublished data). Three homologous recombinants
antigen-specific Th2 responses in vivo. were identified out of 512 colonies using specific probes
located outside the targeting construct as shown in Fig-
ure 1A. Targeted ES cells were injected into B6 blasto-Results
cysts to obtain chimeric mice that transmitted the dis-
rupted locus to F1 offspring. Breeding of CD11/2 miceGeneration of CD1-Deficient Mice
resulted in CD12/2 progeny (Figure 1B) that displayedCD1.1 and CD1.2 are the only CD1 genes found in the
noobvious abnormalities. Mice homozygous for the CD1mouse. They share 95% sequence homology to each
gene mutation did not produce CD1 mRNA in the tissuesother and are arranged in a tail-to-tail fashion on mouse
tested (Figure 1C) and completely lacked surface ex-chromosome 3 (Bradbury et al., 1988). Currently, no
serological reagents can distinguish CD1.1 from CD1.2. pression of CD1 as determined by immunofluorescence
Figure 1. Targeted Disruption of the CD1.1 and CD1.2 Genes in ES Cells
(A) Genomic configuration of the CD1 locus before (top) and after (bottom) homologous recombination with the targeting construct (middle).
Exons (closed boxes), lengths of diagnostic restriction fragments, and the probes used for Southern analysis are shown. Arrows indicate the
transcriptional orientation of neo gene. B, BglII; S, SacI; E, EcoRI, X, XhoI.
(B) Southern blot analysis of F2 DNA. SacI/XhoI-digested DNAs were hybridized with probe 1; the endogenous and targeted alleles are 11
and 7.2 kb, respectively.BglII-digested DNAs were hybridizedwith probe 2; the endogenous and targeted alleles are 9.5 and6.5 kb, respectively.
(C) RT±PCR analysis of CD1 expression in the wild-type, heterozygous, and homozygous CD1 mutant mice. The primers used for PCR are
59-CTGTTGCTGTGGGCATTCCTACAGGT-39 (in Exon 1) and 59-GGACAACCAGGCCACTGGCTTCTCTT-39 (in the undeleted portion of exon
4). HPRT mRNA expression was used as an internal control. Thy, thymus; LN, lymph node; Spl, spleen; BM, bone marrow; Liv, liver; Int,
intestine.
(D) Thymocytes and splenocytes from CD11/1 ( solid line) and CD12/2 (dotted line) mice were stained with an anti-CD1 monoclonal antibody,
5C6, followed by FITC-anti-hamster IgG. Background staining of cells by an isotype-matched control antibody is shown as a gray line.
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Table 1. Frequency of Lymphocyte Subpopulations
in CD1-Deficient Mice
Percentage of Lymphocytes
Tissue Phenotype CD11/1 CD12/2
Thymusa CD41 11.0 6 1.4 13.0 6 2.6
CD81 5.2 6 1.5 6.5 6 3.0
CD41CD81 80.0 6 6.0 76.5 6 7.9
CD42CD82 4.2 6 2.9 3.0 6 2.8
Spleenb CD41 20.2 6 9.1 18.1 6 2.7
CD81 19.3 6 5.8 15.5 6 4.4
B2201 48.8 6 9.7 50.5 6 5.2
Lymph nodes CD41 35.1 6 2.0 38.3 6 6.3
CD81 26.0 6 6.8 25.2 6 6.0
B2201 36.5 6 13 36.0 6 12
Values represent mean (6SD) results obtained from four mice per
Figure 2. Analysis of T Cell Receptor Usage in CD1-Deficient Mice
group. a. The average cell numbers in thymus are 1.64 6 0.4 and
and Littermate Controls 1.57 6 0.9 (3108) in CD11/1 and CD12/2 mice, respectively.
Spleen cells were stained with Cy-chrome-anti-TCRab and appro- b. The average cell numbers in spleen are 0.9 6 0.2 and 1.1 6 0.4
priate antibody to V region that was conjugated with either FITC or (3108) in CD11/1 and CD12/2 mice, respectively.
PE. Results were comparable in 2 experiments.
staining with an anti-CD1 monoclonal antibody, 5C6. CD12/2 mice. The number of lymphocytes and the pro-
portion of CD41, CD81, CD42CD82, and CD4181 cells(Figure 1D).
did not differ significantly between groups (Table 1). We
also analyzed usage of TCR a and b chains by cell-Effect of CD1 on T Cell Development
We compared lymphocytes from the thymus, spleen, surface staining in the spleen but found no significant
alteration in CD12/2 versus control animals (Figure 2).and lymph nodes of wild-type mice with those from
Figure 3. Flow Cytometric Analysis of Lym-
phocytes from CD1 Mutant (2/2) Mice and
Littermate Controls
(A) Thymus or lymph node cells were stained
with FITC-anti-CD3, PE-anti-NK1.1, and Cy-
chrome-anti-CD4. The NK1.11CD31 and
NK1.11CD41 cells are circled, and percent-
ages are indicated. The percentage of
CD42NK11 T cells was also reduced by 50%
to 75%. The results are representative of 6
CD12/2, 3 CD11/2 and 5 CD11/1 mice 4±7
weeks old.
(B) Three-color cell-surface phenotype analy-
sis of liver lymphocytes from CD11/1, CD12/2,
and b2m2/2 mice. Liver lymphocytes were
stained with FITC-anti-TCRab, PE-anti-NK1.1,
and Cy-chrome-anti-CD4. The surface ex-
pression of TCRab was displayed as a histo-
gram (Top). The numbers represent the per-
centage of TCRabint cells relative to the total
population of gated lymphocytes, whereas
the numbers in parentheses represent the
percentage relative to the total TCRab1 cells.
The bottom row depicts CD4 and NK1.1 stain-
ing on the gated TCRabint population. The
NK1.11CD41 cells are circled. The numbers
represent the percentages relative to TCRabint
cells. Results are representative from a total
of four mice per group.
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Figure 4. Semiquantitative PCR of Va14-Ja281 Compared with Va8-
Ca and Ca Transcripts in Various Organs from CD11/1, CD11/2, and
CD12/2 Mice
Input cDNAs were equalized by PCR of serial dilutions from each
sample using primers to detect HPRT expression until comparable
HPRT amplification products were obtained in all diluted samples.
Adjusted cDNAs were then used as templates for amplification of
Ca, Va8-Ca, and Va14-Ja281. The PCR products were run on 2%
agarose gel. Thy, thymus; LN, lymph node; Liv, liver. We also mea-
sured the intensity of positive signals by Southern blotting with 32P-
labeled probes specific for Va14 and Ca regions (data not shown).
The ratio of Va14-Ja281 product between wild-type and CD12/2
mice was as follows: 2:1 in thymus, 4:1 in lymph node, and 10:1 in
liver. Results were comparable in two experiments.
Figure 5. Induction of IL-4 by Anti-CD3 Treatment
(A) Production of IL-4 by thymocytes stimulated with plate-bound
anti-CD3. Thymocytes from CD12/2 mice and wild-type control miceImpaired NK11 T Cell Development were stimulated in anti-CD3-coated microtiter plates.Culture super-
in CD1-Deficient Mice natants were harvested after 48 hr, and IL-4 levels were determined
CD1 has been implicated as the selecting ligand for by ELISA. Bars represent means and standard deviations of tripli-
cate determinations.NK11 T cells, because NK11 T cells are reduced by
(B) IL-4, IFN-g, and IL-2 mRNA expression by splenocytes from anti-nearly 90% in b2m-deficient mice but remain intact in
CD3-treated mice. Mice were injected with 2 mg of anti-CD3, andTAP-deficient mice (Bendelac et al., 1994; Coles and
spleens were removed after 90 min for RNA extraction and reverseRaulet, 1994; Adachi et al., 1995). Indeed, our analysis
transcription. Competitive PCR was performed to compare the rela-
of lymphoid organs of CD12/2 mice showed that the tive amounts of cytokine transcripts. In all cases, the upper band
frequency of NK11 T cells was reduced by nearly 60%± is due to amplification of the competitor construct, and the lower
band is due to the amplification of cDNA. The ratio of IL-4 wild-80% compared with wild-type littermates. This reduc-
type to competitor amplification products is dramatically reducedtion was apparent in both CD41 and CD42 NK11 T cell
in CD12/2 and b2m2/2 mice. HPRT mRNA expression was used aspopulations (Figure 3A). The liver is highly enriched for
an internal control. Results are representative of two experiments.
b2m-dependent CD41 TCRabint lymphocytes. A large
percentage of these cells have a surface phenotype
similar to NK11 T cells, although their lineage relation-
selected on other MHC molecules or which contain twoship with thymic NK11 T cells is not certain (Makino et
rearranged TCR a chains. The decrease in invariantVa14al., 1993; Emoto et al., 1995; Sato et al., 1995). In CD12/2
TCR mRNA expression in CD1-deficient mice is specific,mice, there was marked reduction of TCRabint cells in
since the expression of a Va chain not associated withthe liver. In particular, the CD41 NK1.11 population was
NK11 T cells is not reduced, as shown by equivalentalmost completely absent (Figure 3B).
levels of Va8 transcripts (Figure 4).Many NK11 T cells express an invariant TCR a chain
encoded by the Va14-Ja281 gene with a 1 nt N-region
(Koseki et al., 1991; Lantz and Bendelac, 1994). We ex- Absence of Prompt IL-4 Production
in CD1-Deficient Miceamined the expression of Va14-Ja281 mRNA from multi-
ple organs in CD12/2 and control littermates (Figure 4). Most naive peripheral CD41 cells cannot secrete IL-4
upon primary activation. A population of NK11 thymo-In the liver, where NK11 T cells account for 15%±50%
of T cells, the Va14-Ja281 message was almost unde- cytes can produce large amounts of IL-4 when stimu-
lated by anti-CD3 cross-linking (Bendelac et al., 1992;tectable in CD1 mutant mice, indicating that CD1 is
required for the development and/or expansion of the Arase et al., 1993; Leite-de-Moraes et al., 1995). To de-
termine whether these cells are restricted by CD1, thy-invariant Va141 subset of NK11 T cells. Va14-Ja281
transcripts were also decreased significantly in periph- mocytes were isolated from CD12/2 mice and control
littermates and cultured for 48 hr in anti-CD3-coatederal lymphoid organs, including lymph node (Figure 4),
spleen, bone marrow, and intestine (data not shown). microwells. Thymocytes isolated from control animals
produced large amounts of IL-4 (Figure 5A). In contrast,Va14-Ja281 mRNA was relatively preserved in the thy-
mus of CD12/2 mice, probably reflecting the abundance no detectableamount of IL-4 was induced in thymocytes
isolated from CD12/2 mice.of nonproductive gene rearrangements and unselected
TCRs in this tissue. Peripherally, residual Va14-Ja281 In vivo administration of anti-CD3 mAb rapidly induces
abundant IL-4 production from NK11 Tcells in the spleenmRNAs may be derived from cells whose TCRs were
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Figure 6. IgE Production in Anti-IgD-Treated Mice
Individual mice were injected with 200 ml of goat anti-IgD serum.
Sera were obtained 7 and 8 days later. Serum concentrations of
IgE were determined by ELISA. Bars represent means of duplicate
determinations for individual animals.
of normal mice (Yoshimoto and Paul, 1994). To deter-
mine whether CD1-restricted NK11 T cells are responsi-
ble for this effect, we injected anti-CD3 into CD12/2,
b2m2/2, CD11/2, and wild-type mice and compared cy-
tokine gene expression using competitive RT±PCR (Fig-
ure 5B). CD12/2 mice, like b2m-deficient mice, failed to
produce detectable IL-4 mRNA 90 min after injection
of anti-CD3 monoclonal antibody, while wild-type and
heterozygous animals expressed high levels of IL-4
mRNA at this time point. The levels of IFN-g and IL-2
(Figure 5B) were not diminished in CD12/2 mice com-
pared to controls, indicating that CD1-restricted NK11
T cells are not exclusive sources for the early production
of these cytokines. Thus, both in vitro and in vivo experi-
ments show that CD1-restricted NK11 T cells are re-
sponsible for the rapid and preponderant IL-4 produc-
tion in the anti-CD3 induction model.
Figure 7. Antigen-Specific Response to KLH
(A) Production of IL-4 and IFN-g after immunization with KLH. LymphRole of CD1-Restricted NK11 T Cells
node cells from KLH-immunized mice were in vitro restimulated
in Th2 Responses for 48 hr with KLH, and culture supernatants were analyzed for
One proposed function of rapid IL-4 induction is to direct production of IL-4 and IFN-g by ELISA. Results from two repeated
experiments are shown. Bars represent means and standard devia-the development of naive CD41 T helper precursors into
tions of duplicate determinations. Cytokine levels in wells withoutIL-4-secreting Th2 cells. To determine whether IL-4 pro-
antigen were below 10 U/ml.duced from CD1-restricted NK11 T cells is required for
(B) Proliferative response to KLH. Lymph node cells from KLH-immu-
Th2 differentiation in vivo, we examined antigen- nized animals wererestimualted with various concentrations of KLH.
induced immune responses in CD12/2 mice using two After 48 hr, cultures were pulsed for 24 hr with [3H]thymidine. Results
different challenges that elicit strong Th2 responses. are expressed as mean cpm and standard deviations of duplicate
determinations.First, we examined the effect of CD1-deficiency on IgE
class switching in response to polyclonal stimulation
with anti-IgD, an IL-4-dependent event (Finkelman et
al., 1986). Comparable amounts of IgE were induced in differences in the IL-4 or IFN-g production upon antigen
restimulation could be demonstrated between CD12/2CD12/2 and control littermates 7 and 8 days after injec-
tion of goat anti-mouse IgD serum (Figure 6), suggesting mice and littermate controls (Figure 7A). The antigen-
specific proliferative response was also similar betweenthat the CD1-restricted NK11 T cells are not the major
source of IL-4 in this model. There was also no signifi- groups (Figure 7B). Thus, deficiency in CD1 affected
neither the generation of IL-4 upon antigen restimulationcant difference in basal levels of serum IgE between
CD1-deficient and control mice. nor the ability to generate IgE class switching. Therefore,
rapid production of IL-4 by NK11 T cells is not a require-We next examined the requirement for CD1 in generat-
ing an IL-4-secreting recall response. CD12/2 and con- ment for generating all Th2-type responses.
trol littermate mice were immunized with the particulate
antigen keyhole limpet hemocyanin (KLH) in adjuvant Discussion
and restimulated in vitro in the presence or absence
of KLH. This immunization and restimulation protocol We have shown that in theabsence of CD1, a subpopula-
tion of NK11 T cells is greatly diminished. CD12/2 micetypically yields large amounts of IL-4 and moderate
amounts of IFN-g (Brown et al., 1996a). No significant have significantly reduced expression of Va14-Ja281
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mRNA in peripheral lymphoid organs and in the liver, It is unknown how CD1-restricted NK11 T cells be-
come activated and how their effector functions, i.e.,which is accompanied by impairment of early IL-4 pro-
duction after ligation of TCRs in vivo. The absence of cytokine secretion and cytotoxic activity, are modu-
lated. The restricted nature of their TCR repertoire sug-this cell population has been demonstrated previously
in mice that lack MHC class I molecules owing to a null gests recognition either of antigenswith limited diversity
or of no antigens at all. Candidates include a highlymutation in the b2m gene (Bendelac et al., 1994; Coles
and Raulet, 1994). The TAP-independence and non conserved self ligand, a common element from foreign
pathogens, or CD1 alone, as suggested by the fact thatMHC-linked nature (Adachi et al., 1995) of NK11 T cell
development suggested that CD1 is the selecting ligand some NK11 T cell hybridomas can be activated by CD1
transfectants (Bendelac et al., 1995). As is the case forof this population. Our studies provide formal genetic
evidence that CD1 is responsible for selection of this human CD1 (Kasinrerk et al., 1993), GM-CSF and IL-4
can upregulate the expression of murine CD1 on bone±subset of T cells.
NK11 T cells have been suggested to play a critical marrow derived macrophages (M. M. and C.-R. W., un-
published data). Thus, an increase in the level of ªbareºrole in Th2 differentiation (Yoshimoto et al., 1995a,
1995b). b2m2/2 mice, which lack the NK11 T cell popula- CD1 expression induced by pathogens or inflammation
could trigger the activation of NK11 T cells even withouttion, are unable to produce IgE in response to anti-IgD
treatment. Adoptive transfer of the NK11 T cell popula- the presentation of specific antigens by CD1. Once acti-
vated, cytokine secretion and/or target lysis by NK11 Ttion with T cell-depleted splenocytes from wild-type ani-
mals can restore the ability to produce IgE. In contrast, cells may impact a variety of pathological conditions. It
will now be possible to confirm or exclude the potentialthe ability to produce IgE in response toanti-IgD stimula-
tion is not impaired in CD12/2 mice. It is possible that importance of NK11 T cells in toxoplasmosis (Denkers
et al., 1996), acute bone±marrow graft rejection (Yankel-another b2m-dependent NK11 T cell population is able
to produce IL-4 to compensate for the loss of CD1- evich et al., 1989), and tumor immunity (Hashimoto et
al., 1995).restricted NK11 T cells. Alternatively, the requirement
for NK11 T cells in IgE class switching may be influenced Our studies raise two additional issues about the rela-
tionship of CD1 to T cell development. First, NK11 T cellsby the different geneticbackgrounds (129 3 B6 F1 versus
B6) and ages of the animals. The ability of CD12/2 mice are probably heterogenous and restricted by additional
MHC molecules. The remnant population of NK11 T cellsto generate Th2 responses following subcutaneous im-
munization with protein antigen (KLH) also demon- in CD12/2 animals is greater than that found in b2m-
deficient mice, suggesting that CD1 selects only onestrates that early IL-4 produced from NK11 T cells is
not essential for Th2 differentiation in the present in (but perhaps the preponderant) subset of NK11 T cells.
Studies of TL transgenic mice have raised the possibilityvivo models. This observation is consistent with recent
that other nonclassical class I molecules can selectstudies showing that b2m-deficient mice that lack the
some NK11 T cells (Joyce et al., 1996). Our result, how-early IL-4 burst can generate Th2 responses to several
ever, clearly demonstrates that the near clonotypic se-parasitic microbes and protein allergens (Brown et al.,
lection of the Va14-Ja281 TCR and the characteristic1996b; von der Weid et al., 1996; Zhang et al., 1996). It
early secretion of IL-4 are exclusively CD1-dependent.may be the case that these stimuli induce Th2 differenti-
Second, it is still uncertain whether CD1 serves as theation so strongly that the influence of CD1-restricted
selecting element for cellsother than NK11 T cells. SomeNK11 T cells is overshadowed.
of the human CD1 molecules are recognized by TCRThe canonical TCR usage by murine NK11 T cells
ab1 and gd1 CD42CD82 T cell clones (Porcelli et al.,bears homology to that of a similar subset of human T
1989, 1992; Beckman et al., 1994; Sieling et al., 1995).cells expressing the Va24-JaQ TCR (Dellabona et al.,
Mouse CD1 is recognized by many CD41 hybridomas1993, Porcelli et al., 1993), which most likely would rec-
derived from MHC class II 2/2 mice, most of whichognize human CD1d. The parallel conservation of both
do not express NK1.1 and do have diverse TCR usagethe invariant TCR a chain and the CD1 molecule sug-
(Cardell et al., 1995). CD81 cytotoxic T cells can begests that this receptor±ligand interaction has an impor-
elicited against peptide-loaded murine CD1 transfec-tant immunologic function that has been maintained
tants and secrete IFN-g but not IL-4 upon antigen stimu-throughout evolution. NK11 T cells decline in number
lation (CastanÄo et al., 1995). Because we detect no sig-during the progression of some autoimmune disorders
nificant change in general TCR usage or hematopoieticin both mice and man (Sumida et al., 1995; Mieza et al.,
development, the additional CD1-restricted T cells may1996), and their depletion using an antibody against
be quite heterogenous and form part of the traditionalVa14 can accelerate the course of murine lupus (Mieza
adaptive response, complementing class I- and classet al., 1996). In addition, NK11 T cells are also severely
II-restricted cells. The use of this specifically gene-tar-deficient in SJL and nonobese diabetic (NOD) mice (Yo-
geted animal should allow us to define the function ofshimoto et al., 1995b; Gombert et al., 1996), two strains
CD1-restricted responses in defense against foreignthat have increased susceptibility to autoimmune dis-
pathogens and the prevention of autoimmunity.ease, EAE (experimental allergic encephalomyelitis),
and diabetes, respectively. This raises the possibility
Experimental Proceduresthat Va141 NK11 T cellsmay play a critical role incontrol-
ling the development of autoimmune diseases. Analysis
Generation of CD12/2 Mice
of disease progression in CD12/2 animals on autoim- DNA fragments containing CD1.1 and CD1.2 genes were isolated
mune-prone genetic backgrounds will clarify the role of from a 129/sv genomic DNA phage library (Stratagene). The tar-
geting construct was generated by insertion of a 6.0 kb fragmentNK11 T cells in immune regulation.
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containing exon 1 through the 59 end of exon 4 of the CD1.1 gene by Dr. Jeffrey Bluestone), and spleens were removed 90 min later
for RNA extraction. RNA preparation and reverse transcription wereinto the NotI/XhoI site of pPNT (Tybulewicz et al., 1991) (kindly
provided by Dr. Celeste Simon), followed by insertion of a 2.7 kb conducted as above. Competitive PCR was then used to quantitate
mRNA production of various cytokines (Reiner et al., 1993). In brief,fragment containing exon 1 through part of exon 4 of the CD1.2
gene into the EcoRI/XbaI site of pPNT in the reverse orientation. a multiple cytokine-containing competitor construct (kindly pro-
vided by Dr. Steve Reiner) was used to equalize the amount of inputThis construct was designed to delete 12 kb of sequence, including
most of exon 4 and all the downstream exons of both the CD1.1 cDNA from different mice by adjusting for competition with the HPRT
product. The adjusted amounts of cDNAs and competitor were thenand CD1.2 genes, and to replace these coding regions with the
neomycin resistance gene. Strain 129/sv-derived J-1 embryonic used in the subsequent amplifications with primers specific for mu-
rine IL-4, IFN-g, or IL-2. The ratio of longer competitive productsstem cells (kindly provided by Dr. Philip Ashton-Rickardt) were elec-
troporated with 30 mg of NotI-linearized targeting construct (800 V, to the authentic cytokine products was used to quantitate mRNA
production of cytokines in vivo.3 mF), and G418- and gancyclovir-resistant colonies were screened
for homologous recombination by Southern blot hybridization. ES
clones were injected into blastocysts of B6 mice, and chimeras were In Vivo Treatment of Mice with Anti-IgD Serum
and Quantitation of Serum IgEmated to B6 females. Offspring heterozygous for the mutation were
intercrossed to produce CD12/2 mice, as well as 1/2 and 1/1 Individual mice were injected intravenously with 200 ml of goat-anti-
mouse IgD serum (kindly provided by Dr. Fred Finkelman, Bethesda,littermates. Mice were genotyped by Southern blot analysis.
MD). Animals were bled on day 7 and day 8. Serum IgE level was
determined by a sandwichELISA using commercial mAb pairs (Phar-Flow Cytometric Analysis
Mingen) according to the manufacturer's instructions.Owing to allelic variation in the NK1 marker, we typed animals by
cell surface staining with PE-anti-NK1.1 (PK136) to detect the ex-
Antigen-Specific Response to KLH Immunizationpression of NK1.1 on natural killer cells. Only animals expressing
Mice were immunized in each hind footpad with 75 mg of KLH inNK1.1 were chosen for FACS analysis. Cell suspensions from most
complete Freund's adjuvant. Popliteal lymph nodes were removedtissues of CD12/2 mice and control littermates were prepared by
after 9 days, single cell suspensions were prepared, and duplicatestandard procedures. Lymphocyte cell suspension from perfused
aliquots of 106 cells were cultured in 200 ml of Iscove's media withliver was obtained according to the method described by Goossens
10% FCS in 96-well round-bottomed microtiter plates in the pres-et al. (1990). Cells were stained with various combinations of fluores-
ence or absence of 30 mg/ml of KLH. After 48 hr, IL-4 and IFN-g levelscent-conjugated antibodies and analyzed with a FACSort flow cy-
in culture supernatants were determined by ELISA (PharMingen).tometer (Becton-Dickinson). Antibodies used in this experiment
Proliferative response to in vitro restimulation was measured byinclude FITC-anti-CD3 (2C11), FITC-anti-TCRab (H57±597), FITC-
uptake of [3H]thymidine. Duplicate aliquots of 106 cells were culturedanti-CD8a (53±6.7), FITC-anti-hamster-IgG, PE-anti-NK1.1 (PK136),
with various concentrations of KLH. One microcurie of [3H]thymidinePE-anti-CD8b (53±5.8), Cy-chrome-anti-CD4 (RM4±5), FITC-anti-
per well was added at 48 hr, and DNA was harvested at 72 hr.Va3, PE-anti-Va8, PE-anti-Va11, PE-anti-Vb2, PE-anti-Vb3, PE-anti-
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